Mast Therapeutics Email Formats
Biotechnology Research • 
United States • 1-10 Employees
Company overview
| Headquarters | United States |
| Phone number | +18585520866 |
| Websites | |
| NAICS | 541714 |
| Founded | 1995 |
| Employees | 1-10 |
| Socials |
About Mast Therapeutics
We are a biopharmaceutical company focused on developing therapies for serious or life-threatening diseases. Through our acquisition of SynthRx, Inc. in 2011, we acquired our Membrane Adhesion & Sealant Technology (MAST) platform, which includes proprietary poloxamer-related data and know-how derived from over two decades of clinical, nonclinical and manufacturing experience, and we are leveraging the MAST platform to develop MST-188 for diseases and conditions characterized by microcirculatory insufficiency.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Senior
Belgium
United Kingdom
Israel
South AfricaFrequently asked questions
Mast Therapeutics is located in US.
You can reach Mast Therapeutics at +18585520866.
Mast Therapeutics was founded in 1995, making it 31 years old. The company has established itself as a significant player in its industry over this time.
Mast Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
Mast Therapeutics has raised a total of $15,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.
4.8
40,000 users
